Hypoglycemia can affect people both with diabetes and without, although it’s more common in people with the condition. Some ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

H.C. Wainwright raised the firm’s price target on Amylyx (AMLX) to $12 from $8 and keeps a Buy rating on the shares. Avexitide was well ...

MBX 2109, a once-weekly PTH replacement therapy, shows promising phase 1 results with stable drug concentration and potential to improve patient compliance over daily treatments ... MBX 1416 targeting ...

Yes, it’s technically possible to overdose on Ozempic—but it’s unlikely, says Alexandra Sowa, MD, an internal medicine doctor ...

Digital health tools, artificial intelligence (AI), and wearable devices are leading the way in transforming the landscape ...

The management of type 2 diabetes mellitus is given multifacally treatments following interventions: lifestyle change, medication, and regular monitoring of blood sugar. Monitoring of blood glucose is ...

Piper Sandler lowered shares of Xeris Biopharma (NASDAQ:XERS – Free Report) from an overweight rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Janine E. Curcio and Dr. Robert Lowe provide a seven-point scale based on speech and responsiveness to decide whether or not ...